Zargis Medical Corp. licensed Stethographics Inc.’s lung sounds analysis technology for its telemedicine platform.
The Stamford, Conn.-based Speedus Corp. (NSDQ:SPDE) subsidiary inked an exclusive license agreement for Stethographics’ Food & Drug Administration-approved lung auscultation tool. Stethographics is a Boston-based developer of automated, noninvasive sound analysis products.